ruthenium has been researched along with Hepatocellular Carcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, D; Li, J; Li, Q; Qian, X; Xia, C | 1 |
| Lai, Y; Lu, N; Luo, S; Wang, H; Zhang, P | 1 |
| Dömötör, O; Enyedy, ÉA; Frank, É; Gál, GT; Gašparović, AČ; Kiss, MA; May, NV; Nové, M; Spengler, G | 1 |
| Chai, X; Chen, H; Li, Z; Liu, J; Qin, W; Shi, H; Wang, Y; Zhang, P; Zhang, Q | 1 |
| Chen, R; Ge, Z; Jia, L; Luo, Y; Ma, T; Ma, X; Shen, X; Xu, J; Zhou, T; Zhu, T | 1 |
| Biazzotto, JC; da Silva, RS; de Paula Machado, S; Hamblin, MR; Ramos, LCB; Rodrigues, FP; Slep, LD | 1 |
| Chen, D; Lei, Z; Wang, X; Yuan, J; Zhu, F | 1 |
| Gu, W; Lu, Y; Shen, T; Yang, H | 1 |
| Chen, WL; Chen, YH; Cheng, CC; Chiou, ML; Lee, WJ; Pai, CW; Wang, YH; Wen, CC | 1 |
| Hua, X; Liu, S; Wang, L; Wei, W; Wu, Y; Zhou, H; Zhou, Z | 1 |
| Anghileri, LJ | 1 |
| Oda, T; Utsumi, K | 1 |
12 other study(ies) available for ruthenium and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Fabrication of novel ruthenium loaded silk fibroin nanomaterials for fingolimod release improved antitumor efficacy in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Drug Delivery Systems; Fibroins; Fingolimod Hydrochloride; Liver Neoplasms; Nanostructures; Ruthenium; Silk; Tissue Distribution | 2022 |
A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Ferroptosis; Hep G2 Cells; Humans; Lipid Peroxides; Liver Neoplasms; Prodrugs; Purines; Reactive Oxygen Species; Ruthenium; Sorafenib | 2022 |
Solution equilibrium, structural and cytotoxicity studies on Ru(η
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Coordination Complexes; Copper; Cymenes; Female; Humans; Liver Neoplasms; Organometallic Compounds; Pyrazoles; Ruthenium; Thiosemicarbazones; Tumor Cells, Cultured | 2020 |
A HCBP1 peptide conjugated ruthenium complex for targeted therapy of hepatoma.
Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; Coordination Complexes; Hep G2 Cells; Humans; Liver Neoplasms; Oligopeptides; Ruthenium | 2020 |
Using fluorescently-labeled magnetic nanocomposites as a dual contrast agent for optical and magnetic resonance imaging.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Fluorescent Dyes; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Magnesium Compounds; Magnetic Resonance Imaging; Magnetite Nanoparticles; Nanocomposites; Nanotubes; Optical Imaging; Rabbits; Ruthenium; Silicon Compounds | 2017 |
Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex.
Topics: Animals; Antibodies; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Immunoconjugates; Liver Neoplasms; Male; Mitochondria, Liver; Mitochondrial Swelling; Nitric Oxide; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Ruthenium; Voltage-Dependent Anion Channels | 2018 |
Ruthenium complex Λ-WH0402 induces hepatocellular carcinoma LM6 (HCCLM6) cell death by triggering the Beclin-1-dependent autophagy pathway.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Cell Line, Tumor; Coordination Complexes; Humans; Liver Neoplasms; Membrane Proteins; Ruthenium; Signal Transduction | 2015 |
Ruthenium Complexes Induce HepG2 Human Hepatocellular Carcinoma Cell Apoptosis and Inhibit Cell Migration and Invasion through Regulation of the Nrf2 Pathway.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; NF-E2-Related Factor 2; Organometallic Compounds; Ruthenium; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |
A novel phenotype-based approach for systematically screening antiproliferation metallodrugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Drug Screening Assays, Antitumor; Embryo, Nonmammalian; Humans; Liver Neoplasms; Microscopy, Fluorescence; Microscopy, Interference; NF-kappa B; Organometallic Compounds; Phenotype; Ruthenium; Tumor Suppressor Protein p53; Zebrafish | 2009 |
Signal amplification cytosensor for evaluation of drug-induced cancer cell apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Biosensing Techniques; Carcinoma, Hepatocellular; Cell Membrane; Electrochemical Techniques; Humans; Liver Neoplasms; Luminescent Measurements; Nanoparticles; Nanotubes, Carbon; Oligopeptides; Phosphatidylserines; Ruthenium; Silicon Dioxide; Tumor Cells, Cultured | 2012 |
Radioactive ruthenium red accumulation by tumors: a potential scanning agent.
Topics: Animals; Binding Sites; Carcinoma, Hepatocellular; Coloring Agents; Glycosaminoglycans; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Radionuclide Imaging; Rats; Ruthenium | 1975 |
Ruthenium-red-induced cell agglutination and surface glycoprotein and mucopolysaccharide.
Topics: Agglutination; Agglutination Tests; Animals; Binding Sites; Carcinoma, Hepatocellular; Cetylpyridinium; Chondroitin; Chromatography; Coloring Agents; Electrophoresis, Polyacrylamide Gel; Glucose; Glycoproteins; Glycosaminoglycans; Hyaluronoglucosaminidase; Lanthanum; Liver Neoplasms; Mice; Microscopy, Electron; Neoplasms, Experimental; Papain; Rats; Ruthenium; Staining and Labeling; Trypsin | 1973 |